Growth Metrics

Standard Biotools (LAB) Return on Invested Capital (2016 - 2025)

Standard Biotools (LAB) has disclosed Return on Invested Capital for 15 consecutive years, with 0.29% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 22.0% to 0.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.29% through Dec 2025, down 22.0% year-over-year, with the annual reading at 0.25% for FY2025, 14.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.29% at Standard Biotools, down from 0.02% in the prior quarter.
  • The five-year high for Return on Invested Capital was 13.11% in Q2 2022, with the low at 1.38% in Q1 2022.
  • Average Return on Invested Capital over 5 years is 0.97%, with a median of 0.02% recorded in 2025.
  • The sharpest move saw Return on Invested Capital soared 1360bps in 2022, then plummeted -1194bps in 2023.
  • Over 5 years, Return on Invested Capital stood at 0.67% in 2021, then surged by 533bps to 2.92% in 2022, then crashed by -96bps to 0.12% in 2023, then tumbled by -162bps to 0.07% in 2024, then plummeted by -298bps to 0.29% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.29%, 0.02%, and 0.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.